Last reviewed · How we verify
NCT07422142
A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetic Profile of Gastrodin Injection in Healthy Chinese Subjects
Phase 1 trial testing gastrodin injection；placebo in Delirium in 54 participants. Not yet recruiting.
30 September 2026
Quick facts
| Lead sponsor | Kunming Pharmaceuticals, Inc. |
|---|---|
| Phase | Phase 1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 54 |
| Start date | 1 March 2026 |
| Primary completion | 30 September 2026 |
| Estimated completion | 30 September 2026 |
| Sites | 1 location across China |
Drugs / interventions tested
- gastrodin injection；placebo — full drug profile →
- gastrodin injection；placebo — full drug profile →
Conditions studied
- Delirium — all drugs for Delirium →
Sponsor
Kunming Pharmaceuticals, Inc. — full company profile →
Who can join
Adults 18 to 65, any sex, with Delirium. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a single-center, double-blind study to evaluate the safety, tolerability, pharmacokinetics of Gastrodin Injection in healthy Subjects
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07422142
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Delirium
Currently open trials in the same condition.
- NCT07348471 — Fecal Microbiota Transplantation for the Treatment of ICU Delirium · NA · recruiting
- NCT06969287 — Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery · Phase 3 · recruiting
- NCT07369258 — Clinical Application of Listening to Music to Prevent Delirium in the Intensive Care Unit · NA · recruiting
- NCT07488468 — Quality Improvement Project to Reduce Preoperative Fasting Times Before Elective Procedures · recruiting
- NCT07136207 — Development and Validation of Delirium Recognition Using Computer Vision in Neuro-critical Patients · recruiting
Other Kunming Pharmaceuticals, Inc. trials
Trials by the same sponsor.
- NCT07279493 — Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke · Phase 2 · recruiting
- NCT06867406 — A Trial to Evaluate KPC000154 Tablets in Healthy Subjects · Phase 1 · not yet recruiting
- NCT05745311 — Study of the KPCXM18 Injection for Treatment of Acute Ischemic Stroke · Phase 2 · unknown
- NCT04906473 — Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors · Phase 1 · unknown
- NCT04673799 — Comparing of the Pharmacokinetics, Immunogenicity and Safety of MV088 and Prolia® in Healthy Adults. · Phase 1 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07422142 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kunming Pharmaceuticals, Inc.
- Last refreshed: 19 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07422142.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing